Literature DB >> 1689508

Biologic response modifiers in non-Hodgkin's lymphomas.

T A Gilewski1, J M Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1689508

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2.

Authors:  L H Caldera; M Leon-Ponte; G Acquatella; N E Bianco; I Blanca
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Maintenance therapy with interferon alfa 2b in patients with diffuse large cell lymphoma.

Authors:  A Avilés; J C Díaz-Maqueo; E L García; A Talavera; R Guzmán
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

Review 3.  The role of interferon as maintenance therapy in malignant lymphoma.

Authors:  A Avilés
Journal:  Med Oncol       Date:  1997 Sep-Dec       Impact factor: 3.064

Review 4.  Treatment of B-cell lymphoma using peptides. A novel concept.

Authors:  K S Lam
Journal:  West J Med       Date:  1993-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.